XML 47 R35.htm IDEA: XBRL DOCUMENT v3.25.1
Stock-based compensation (Tables)
3 Months Ended
Mar. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Black-Scholes Option-Pricing Model
The following table presents, on a weighted average basis, the assumptions used in the Black-Scholes option-pricing model to determine the grant-date fair value of stock options granted to employees and directors:
Three Months Ended March 31,
20252024
Risk-free interest rate 4.3 %4.1 %
Expected term (in years)6.16.0
Expected volatility51.0 %49.5 %
Expected dividend yield%%
Schedule of Stock Option Activity
The following table summarizes the Company’s stock option activity since December 31, 2024:
Number of
shares
Weighted
average
exercise price
Weighted
average
remaining
contractual term
Aggregate
intrinsic value
(in years)(in thousands)
Outstanding as of December 31, 20246,296,505$2.39 6.18$135 
Granted 1,011,0003.50 
Exercised(273,385)1.07 $330 
Expired(73,864)8.32 
Forfeited(6,530)0.98 
Outstanding as of March 31, 20256,953,726$2.54 6.75$7,985 
Options vested and expected to vest as of March 31, 20256,953,726$2.54 6.75$7,985 
Options exercisable as of March 31, 20254,504,464$2.65 5.57$5,795 
Schedule of Restricted Stock Units Activity
The following table summarizes the Company's restricted stock units activity since December 31, 2024:
Number of
shares
Weighted
average
fair value
Unvested as of December 31, 20241,941,688$1.46 
Granted1,039,500$3.50 
Vested(334,137)$3.13 
Forfeited(15,151)$0.98 
Unvested as of March 31, 20252,631,900$2.05 
Schedule of ESPP Black-Scholes Option-Pricing Model The following weighted average assumptions were used in the calculation of fair value of shares under the 2021 ESPP at the grant date for both the three months ended March 31, 2025 and 2024:
Three Months Ended March 31,
20252024
Risk-free interest rate4.5 %5.4 %
Expected term (in years)0.50.5
Expected volatility44.9 %49.4 %
Expected dividend yield%%
Schedule of Stock-Based Compensation Expense
Stock-based compensation expense was classified in the condensed consolidated statements of operations as follows (in thousands):
Three Months Ended March 31,
20252024
Cost of revenue$92 $147 
Research and development140 129 
Sales and marketing90 105 
General and administrative720 704 
Total stock-based compensation expense$1,042 $1,085